305 related articles for article (PubMed ID: 28231007)
21. Molecular Dynamics and Physical Stability of Amorphous Nimesulide Drug and Its Binary Drug-Polymer Systems.
Knapik J; Wojnarowska Z; Grzybowska K; Tajber L; Mesallati H; Paluch KJ; Paluch M
Mol Pharm; 2016 Jun; 13(6):1937-46. PubMed ID: 27149568
[TBL] [Abstract][Full Text] [Related]
22. Relaxation dynamics and crystallization study of sildenafil in the liquid and glassy states.
Kolodziejczyk K; Paluch M; Grzybowska K; Grzybowski A; Wojnarowska Z; Hawelek L; Ziolo JD
Mol Pharm; 2013 Jun; 10(6):2270-82. PubMed ID: 23594226
[TBL] [Abstract][Full Text] [Related]
23. Classification of solid dispersions: correlation to (i) stability and solubility (ii) preparation and characterization techniques.
Meng F; Gala U; Chauhan H
Drug Dev Ind Pharm; 2015; 41(9):1401-15. PubMed ID: 25853292
[TBL] [Abstract][Full Text] [Related]
24. Solubility advantage from amorphous etoricoxib solid dispersions.
Dani P; Puri V; Bansal AK
Drug Dev Ind Pharm; 2014 Jan; 40(1):92-101. PubMed ID: 23301771
[TBL] [Abstract][Full Text] [Related]
25. Mutual Impact of Phase Separation/Crystallization and Water Sorption in Amorphous Solid Dispersions.
Luebbert C; Wessner M; Sadowski G
Mol Pharm; 2018 Feb; 15(2):669-678. PubMed ID: 29309155
[TBL] [Abstract][Full Text] [Related]
26. Influence of PVP/VA copolymer composition on drug-polymer solubility.
Rask MB; Knopp MM; Olesen NE; Holm R; Rades T
Eur J Pharm Sci; 2016 Mar; 85():10-7. PubMed ID: 26826280
[TBL] [Abstract][Full Text] [Related]
27. The potential of small-scale fusion experiments and the Gordon-Taylor equation to predict the suitability of drug/polymer blends for melt extrusion.
Forster A; Hempenstall J; Tucker ; Rades T
Drug Dev Ind Pharm; 2001 Jul; 27(6):549-60. PubMed ID: 11548862
[TBL] [Abstract][Full Text] [Related]
28. Investigation of Drug-Excipient Interactions in Biclotymol Amorphous Solid Dispersions.
Schammé B; Couvrat N; Tognetti V; Delbreilh L; Dupray V; Dargent É; Coquerel G
Mol Pharm; 2018 Mar; 15(3):1112-1125. PubMed ID: 29328661
[TBL] [Abstract][Full Text] [Related]
29. Enhancement of the physical stability of amorphous indomethacin by mixing it with octaacetylmaltose. inter and intra molecular studies.
Kaminska E; Adrjanowicz K; Zakowiecki D; Milanowski B; Tarnacka M; Hawelek L; Dulski M; Pilch J; Smolka W; Kaczmarczyk-Sedlak I; Kaminski K
Pharm Res; 2014 Oct; 31(10):2887-903. PubMed ID: 24831310
[TBL] [Abstract][Full Text] [Related]
30. The Development of Quasi-isothermal Calorimetry for the Measurement of Drug-Polymer Miscibility and Crystallization Kinetics: Olanzapine-Loaded PLGA Microparticles.
Askin S; Zhao M; Gonçalves AD; Gaisford S; Craig DQM
Mol Pharm; 2018 Aug; 15(8):3332-3342. PubMed ID: 29933697
[TBL] [Abstract][Full Text] [Related]
31. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
Dhumal RS; Shimpi SL; Paradkar AR
Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109
[TBL] [Abstract][Full Text] [Related]
32. What Are the Important Factors That Influence API Crystallization in Miscible Amorphous API-Excipient Mixtures during Long-Term Storage in the Glassy State?
Newman A; Zografi G
Mol Pharm; 2022 Feb; 19(2):378-391. PubMed ID: 34378939
[TBL] [Abstract][Full Text] [Related]
33. Drug-Excipient Interactions: Effect on Molecular Mobility and Physical Stability of Ketoconazole-Organic Acid Coamorphous Systems.
Fung MH; DeVault M; Kuwata KT; Suryanarayanan R
Mol Pharm; 2018 Mar; 15(3):1052-1061. PubMed ID: 29309158
[TBL] [Abstract][Full Text] [Related]
34. The Stabilization of Amorphous Zopiclone in an Amorphous Solid Dispersion.
Milne M; Liebenberg W; Aucamp M
AAPS PharmSciTech; 2015 Oct; 16(5):1190-202. PubMed ID: 25732372
[TBL] [Abstract][Full Text] [Related]
35. Glass Transition Dynamics and Physical Stability of Amorphous Griseofulvin in Binary Mixtures with Low-
Tu W; Knapik-Kowalczuk J; Chmiel K; Paluch M
Mol Pharm; 2019 Aug; 16(8):3626-3635. PubMed ID: 31287704
[TBL] [Abstract][Full Text] [Related]
36. Continuous production of itraconazole-based solid dispersions by hot melt extrusion: Preformulation, optimization and design space determination.
Thiry J; Lebrun P; Vinassa C; Adam M; Netchacovitch L; Ziemons E; Hubert P; Krier F; Evrard B
Int J Pharm; 2016 Dec; 515(1-2):114-124. PubMed ID: 27720874
[TBL] [Abstract][Full Text] [Related]
37. Amorphous Drug-Polymer Salt with High Stability under Tropical Conditions and Fast Dissolution: The Case of Clofazimine and Poly(acrylic acid).
Gui Y; McCann EC; Yao X; Li Y; Jones KJ; Yu L
Mol Pharm; 2021 Mar; 18(3):1364-1372. PubMed ID: 33522821
[TBL] [Abstract][Full Text] [Related]
38. Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.
Tian Y; Caron V; Jones DS; Healy AM; Andrews GP
J Pharm Pharmacol; 2014 Feb; 66(2):256-74. PubMed ID: 24192445
[TBL] [Abstract][Full Text] [Related]
39. Amorphous stabilization and dissolution enhancement of amorphous ternary solid dispersions: combination of polymers showing drug-polymer interaction for synergistic effects.
Prasad D; Chauhan H; Atef E
J Pharm Sci; 2014 Nov; 103(11):3511-3523. PubMed ID: 25196860
[TBL] [Abstract][Full Text] [Related]
40. Amino acids as co-amorphous excipients for simvastatin and glibenclamide: physical properties and stability.
Laitinen R; Löbmann K; Grohganz H; Strachan C; Rades T
Mol Pharm; 2014 Jul; 11(7):2381-9. PubMed ID: 24852326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]